A Breathalyzer for Disease
Our Mission: To save 100,000 lives and $1.5B in healthcare costs.
Our Vision: The global leader in Breath Biopsy for early detection and precision medicine.
Owlstone Announces Investment from Bill & Melinda Gates Foundation
Owlstone Medical secures $6.5 million to support the development of breath-based diagnostics for infectious diseases.
The Microbiome Content Pack
Download our Microbiome Content Pack and receive exclusive content on how breath analysis can be used for gut microbiome research.
Owlstone Publishes New VOC Atlas Paper
“High-quality identification of volatile organic compounds (VOCs) originating from breath”, published in Metabolomics. Building the foundations of our soon-to-release Breath Biopsy VOC Atlas®.
Breath Biopsy Conference 2024
Join us for our two day online conference where the key areas of breath research will be explored through talks, poster sessions and discussions.
Bring Breath analysis and VOC biomarker research to your own lab with our complete range of Breath Biopsy Research Products
Find out what Breath Biopsy can do with our webinar on clinical applications.
SOME OF OUR CUSTOMERS
